$NKTX Stock Is up 12% Today. Here's What We See in Our Data.
Nkarta (NKTX) Upgraded to Buy: Here's Why
FDA Staff Cuts Are Already Impacting Regulatory Work, Biotech Leaders Warn
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Nkarta (NKTX) and Regeneron (REGN)
Nkarta to Participate in an April Investor Conference
Nkarta NKTX +44% Earnings; Soleno SLNO +38% Approval
William Blair Maintains Nkarta(NKTX.US) With Buy Rating
Needham Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $11
12 Health Care Stocks Moving In Thursday's Intraday Session
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?
Express News | Nkarta Shares Are Trading Higher After the Company Reported a Q4 EPS Beat. Additionally, Several Firms Maintained Buy Ratings on the Stock
$NKTX Stock Is up 53% Today. Here's What We See in Our Data.
Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR), Perspective Therapeutics (CATX) and Nkarta (NKTX)
Nkarta Is Maintained at Buy by Stifel
Nkarta Price Target Maintained With a $11.00/Share by Needham
Express News | HC Wainwright & Co. Reiterates Buy on Nkarta, Maintains $18 Price Target
Nkarta Analyst Ratings
Express News | Nkarta Inc : Stifel Cuts Target Price to $14 From $15
Nkarta's Strategic Restructuring and NKX019 Progress Drive Buy Rating
TD Cowen Maintains Nkarta(NKTX.US) With Buy Rating